Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Benefit of the Blood Glucose Self Monitoring and a Regular Three-monthly Hemoglobin A1c Profile in Patients With Type 2-diabetes and Conventional Insulin Therapy

NCT00688363 is registered in ClinicalTrials.gov with Deutsche Diabetes Gesellschaft as lead sponsor.

NCT NCT00688363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00688363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Benefit of the Blood Glucose Self Monitoring and a Regular Three-monthly Hemoglobin A1c Profile in Patients With Type 2-diabetes and Conventional Insulin Therapy
Lead sponsor
Deutsche Diabetes Gesellschaft
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2003
Completion date
December 31, 2008
Enrollment
300 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes